Cargando…
MicroRNA-302s Might Regulate ARL4C-Mediated Gastric Cancer Progression via p53 Signaling: Bioinformatics Analysis and Experiments Validation
BACKGROUND: Our previous studies demonstrate that ARL4C is the most critical clinical biomarker for gastric cancer (GC) patients among ARL family members (ARLs) and functions as an oncogene in GC. However, its underlying mechanisms in GC need to be further illustrated. In this study, we aim to explo...
Autores principales: | Xie, Ning, Pan, Yifei, Wu, Jian, Bai, Yunfan, Xiao, Cailan, Gao, Xiaoliang, Wang, Jinhai, Liu, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053516/ https://www.ncbi.nlm.nih.gov/pubmed/33880033 http://dx.doi.org/10.2147/OTT.S282992 |
Ejemplares similares
-
ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments
por: Xie, Ning, et al.
Publicado: (2021) -
The microRNA and the perspectives of miR-302
por: Chen, Emily Yen Yu, et al.
Publicado: (2019) -
ARL11 correlates with the immunosuppression and poor prognosis in breast cancer: A comprehensive bioinformatics analysis of ARL family members
por: Xie, Ning, et al.
Publicado: (2022) -
Down-regulation of miR-302b, an ESC-specific
microRNA, in Gastric Adenocarcinoma
por: Khalili, Mitra, et al.
Publicado: (2012) -
Application of the microRNA‐302/367 cluster in cancer therapy
por: Liu, Jiajia, et al.
Publicado: (2020)